4//SEC Filing
Trevejo Jose M. 4
Accession 0001661539-22-000005
CIK 0001819790other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:36 PM ET
Size
7.7 KB
Accession
0001661539-22-000005
Insider Transaction Report
Form 4
Trevejo Jose M.
CHIEF MEDICAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-01+116,424→ 116,424 totalExercise: $20.64Exp: 2032-01-31→ Common Stock (116,424 underlying) - Award
Restricted Stock Units
2022-02-01+30,197→ 30,197 total→ Common Stock (30,197 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001661539
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:36 PM ET
- Size
- 7.7 KB